Janssen And Amgen Settle Patent Row Over Stelara Biosimilar
Janssen and Amgen told a Delaware federal judge Monday they've agreed to settle a dispute over Janssen's attempt to block Amgen from launching a copycat version of its blockbuster immunosuppressive product...To view the full article, register now.
Already a subscriber? Click here to view full article